Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2005; 93(01): 180-182
DOI: 10.1055/s-0037-1616164
DOI: 10.1055/s-0037-1616164
Letters to the Editor
A functional serotonin transporter (SLC6A4) polymorphism modifies the association of smoking and diabetes with asymptomatic carotid atherosclerosis
Authors
Financial support: This work was supported by the German Federal Ministry of Education, Science, Research, and Technology (grant 01 GG 9845/5, 01ZZ96030) and from the Ministry for Education, Research and Cultural Affairs and the Ministry for Social Affairs of the State Mecklenburg-Western Pomerania.
Further Information
Correspondence to:
Birger Wolff, MD
Klinik für Innere Medizin B
Ernst-Moritz-Arndt-Universität Greifswald
Friedrich-Loeffler-Straße 23 a
17487 Greifswald, Germany
Phone: +49–3834–866656
Fax: +49–3834–866657
Email: bwolff@pop.uni-greifswald.de
Publication History
Received
26 April 2004
Accepted after resubmission
28 October 2004
Publication Date:
15 December 2017 (online)
Scroll to top
* Both authors contributed equally.
-
References
- 1 Lesch KP, Bengel D, Heils A. et al Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-31.
- 2 Greenberg BD, Tolliver TJ, Huang SH. et al Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999; 88: 83-7.
- 3 Hanna GL, Himle JA, Curtis GC. et al Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology 1998; 18: 102-11.
- 4 Fumeron F, Betoulle D, Nicaud V. et al Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Temoins de l'Infarctus du Myocarde (ECTIM). Circulation 2002; 105: 2943-5.
- 5 Arinami T, Ohtsuki T, Yamakawa-Kobayashi K. et al A synergistic effect of serotonin transporter gene polymorphism and smoking in association with CHD. Thromb Haemost 1999; 81: 853-6.
- 6 Coto E, Reguero JR, Alvarez V. et al 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Clin Sci 2003; 104: 241-5.
- 7 Craven TE, Ryu JE, Espeland MA. et al Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. Circulation 1990; 82: 1230-42.
- 8 Wolff B, Volzke H, Ludemann J. et al Association between high serum ferritin levels and carotid atherosclerosis in the Study of Health in Pomerania (SHIP). Stroke 2004; 35: 435-57.
- 9 Hioki H, Aoki N, Kawano K. et al Acute effects of cigarette smoking on platelet-dependent thrombin generation. Eur Heart J 2001; 22: 56-61.
- 10 Haramaki N, Ikeda H, Takajo Y. et al Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione. Arterioscler Thromb Vasc Biol 2001; 21: 1852-6.
- 11 Markovitz JH, Tolbert L, Winders SE. Increased serotonin receptor density and platelet GPIIb/IIIa activation among smokers. Arterioscler Thromb Vasc Biol 1999; 19: 762-6.
- 12 Li Y, Woo V, Bose R. Platelet hyperactivity and abnormal calcium homeostasis in diabetes mellitus. Am J Physiol Heart Circ Physiol 2001; 280: 1480-9.
- 13 Pietraszek MH, Takada Y, Takada A. et al Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitus. Thromb Res 1992; 66: 765-74.
Correspondence to:
Birger Wolff, MD
Klinik für Innere Medizin B
Ernst-Moritz-Arndt-Universität Greifswald
Friedrich-Loeffler-Straße 23 a
17487 Greifswald, Germany
Phone: +49–3834–866656
Fax: +49–3834–866657
Email: bwolff@pop.uni-greifswald.de
-
References
- 1 Lesch KP, Bengel D, Heils A. et al Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-31.
- 2 Greenberg BD, Tolliver TJ, Huang SH. et al Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999; 88: 83-7.
- 3 Hanna GL, Himle JA, Curtis GC. et al Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology 1998; 18: 102-11.
- 4 Fumeron F, Betoulle D, Nicaud V. et al Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Temoins de l'Infarctus du Myocarde (ECTIM). Circulation 2002; 105: 2943-5.
- 5 Arinami T, Ohtsuki T, Yamakawa-Kobayashi K. et al A synergistic effect of serotonin transporter gene polymorphism and smoking in association with CHD. Thromb Haemost 1999; 81: 853-6.
- 6 Coto E, Reguero JR, Alvarez V. et al 5-Hydroxytryptamine 5-HT2A receptor and 5-hydroxytryptamine transporter polymorphisms in acute myocardial infarction. Clin Sci 2003; 104: 241-5.
- 7 Craven TE, Ryu JE, Espeland MA. et al Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. Circulation 1990; 82: 1230-42.
- 8 Wolff B, Volzke H, Ludemann J. et al Association between high serum ferritin levels and carotid atherosclerosis in the Study of Health in Pomerania (SHIP). Stroke 2004; 35: 435-57.
- 9 Hioki H, Aoki N, Kawano K. et al Acute effects of cigarette smoking on platelet-dependent thrombin generation. Eur Heart J 2001; 22: 56-61.
- 10 Haramaki N, Ikeda H, Takajo Y. et al Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione. Arterioscler Thromb Vasc Biol 2001; 21: 1852-6.
- 11 Markovitz JH, Tolbert L, Winders SE. Increased serotonin receptor density and platelet GPIIb/IIIa activation among smokers. Arterioscler Thromb Vasc Biol 1999; 19: 762-6.
- 12 Li Y, Woo V, Bose R. Platelet hyperactivity and abnormal calcium homeostasis in diabetes mellitus. Am J Physiol Heart Circ Physiol 2001; 280: 1480-9.
- 13 Pietraszek MH, Takada Y, Takada A. et al Blood serotonergic mechanisms in type 2 (non-insulin-dependent) diabetes mellitus. Thromb Res 1992; 66: 765-74.